Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
- J. Baeten, D. Donnell, C. Celum
- MedicineNew England Journal of Medicine
- 1 August 2012
Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women, and both study medications significantly reduced the HIV- 1 incidence among both men andWomen.
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
- Cristian Pop-Eleches, H. Thirumurthy, D. Bangsberg
- Medicine, PsychologyAIDS (London)
- 27 March 2011
It is suggested that SMS reminders may be an important tool to achieve optimal treatment response in resource-limited settings and be used to promote high adherence to antiretroviral therapy.
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
- P. Braitstein, M. Brinkhof, M. Egger
- MedicineThe Lancet
- 11 March 2006
Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators
- E. Mills, J. Nachega, C. Cooper
- Medicine, PsychologyPLoS Medicine
- 1 November 2006
Important barriers to adherence are consistent across multiple settings and countries, and Clinicians should use this information to engage in open discussion with patients to promote adherence and identify barriers and facilitators within their own populations.
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.
- E. Mills, J. Nachega, D. Bangsberg
- MedicineJAMA
- 9 August 2006
The findings indicate that favorable levels of adherence, much of which was assessed via patient self-report, can be achieved in sub-Saharan African settings and that adherence remains a concern in North America.
Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana
- S. Weiser, W. Wolfe, R. Marlink
- Medicine, Political ScienceJournal of Acquired Immune Deficiency Syndromes
- 1 November 2003
ARV adherence rates in Botswana were comparable with those seen in developed countries, as health care providers were often unable to identify which patients adhere to their ARV regimens.
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
- D. Bangsberg, F. Hecht, A. Moss
- MedicineAIDS (London)
- 10 March 2000
A substantial proportion of homeless and marginally housed individuals had good adherence to PI therapy and a strong relationship was found between independent methods of measuring adherence and concurrent viral suppression.
Routine HIV Testing in Botswana: A Population-Based Study on Attitudes, Practices, and Human Rights Concerns
- S. Weiser, M. Heisler, V. Iacopino
- MedicinePLoS Medicine
- 1 July 2006
Routine testing appears to be widely supported and may reduce barriers to testing in Botswana, and measures should be implemented to assure true informed consent and human rights safeguards, including protection from HIV-related discrimination and protection of women against partner violence related to testing.
Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis
- I. Katz, Annemarie E Ryu, A. Tsai
- Psychology, BiologyJournal of the International AIDS Society
- 31 October 2013
This review undertook a systematic assessment of the relationship between HIV‐related stigma and ART adherence to systematically assess the relationship with ART adherence itself.
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.
- D. Bangsberg, S. Perry, A. Moss
- Medicine, BiologyAIDS (London)
- 15 June 2001
The introduction of highly active antiretroviral therapy (HAART) has produced a dramatic reduction in mortality among HIV-infected individuals [1–4]. Whereas the level of adherence to HAART is…
...
...